申请人:Dimauro F. Erin
公开号:US20070072862A1
公开(公告)日:2007-03-29
The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including autoimmune disease and inflammation. In one embodiment, the compounds have a general Formula I
wherein A
1
, A
2
, A
3
, A
4
, L, R
1
, R
2
and R
3
are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of the present invention, methods of use such as treatment of Lck and/or c-Kit kinase mediated diseases by administering the compounds of the invention, or compositions including one or more compounds of the invention, and intermediates and processes useful for the preparation of compounds of the present invention.
本发明涵盖了一类新的化合物,用于预防和治疗蛋白激酶介导的疾病,包括自身免疫疾病和炎症。在一个实施例中,这些化合物具有一般的化学式I,其中A1、A2、A3、A4、L、R1、R2和R3在此处定义。本发明还涵盖了包括本发明的一种或多种化合物的药物组合物,使用方法如通过给予本发明的化合物治疗Lck和/或c-Kit激酶介导的疾病,或包括本发明的一种或多种化合物的组合物,以及用于制备本发明化合物的中间体和方法。